36. Cancer Discov. 2018 Mar;8(3):272-275. doi: 10.1158/2159-8290.CD-18-0091.Driver Oncogenes but Not as We Know Them: Targetable Fusion Genes in BreastCancer.Natrajan R(1), Tutt ANJ(1)(2), Lord CJ(1)(3).Author information: (1)The Breast Cancer Now Toby Robins Research Centre, The Institute of CancerResearch, London, United Kingdom. Chris.Lord@icr.ac.uk rachael.natrajan@icr.ac.ukandrew.tutt@icr.ac.uk.(2)The Breast Cancer Now Research Unit at King's College Hospital, London, UnitedKingdom.(3)CRUK Gene Function Laboratory, The Institute of Cancer Research, London,United Kingdom.Two reports in this issue of Cancer Discovery outline how the genomic compositionof tumors, including the presence of intragenic gene fusions, could inform theselection of treatment approaches in aggressive forms of the disease. CancerDiscov; 8(3); 272-5. ©2018 AACRSee related article by Matissek et al., p. 336See related article by Liu et al., p. 354.©2018 American Association for Cancer Research.DOI: 10.1158/2159-8290.CD-18-0091 PMID: 29500329 